Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Plaque REgression With Cholesterol Absorption Inhibitor or Synthesis Inhibitor Evaluated by IntraVascular UltraSound (PRECISE-IVUS)

This study has been completed.
Information provided by (Responsible Party):
Hisao Ogawa, Kumamoto University Identifier:
First received: January 5, 2010
Last updated: March 30, 2015
Last verified: March 2015